CXCL8 and familial pancreatic carcinoma: In pancreatic cancer, doxycycline showed to affect PC growth by activating proapoptotic genes and suppressing antiapoptotic genes, perturbating cell cycle and inhibiting the expression of the proangiogenic IL-8 [34,35].